OMNICELL,INC. (NASDAQ:OMCL) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersItem 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On June 5, 2018, at a meeting of the Compensation Committee (the “Committee”) of the Board of Directors of Omnicell,Inc. (the “Company”), the Committee approved 2018 annualized base salaries for the Company’s executive officers as set forth in the table below. The annualized base salaries are effective as of June 25, 2018.
|
Name |
Title |
2018 Annualized BaseSalary |
|
|
Randall A. Lipps |
Chairman, President and Chief Executive Officer |
$ |
700,000 |
|
Dan S. Johnston |
Executive Vice President and Chief Legal & Administrative Officer |
$ |
330,000 |
|
Peter J. Kuipers |
Executive Vice President and Chief Financial Officer |
$ |
425,000 |
|
Nhat H. Ngo |
Executive Vice President, Marketing, Strategy and Business Development |
$ |
365,000 |
|
Scott P. Seidelmann(1) |
Executive Vice President and Chief Commercial Officer |
$ |
400,000 |
|
Robin G. Seim |
President, Global Automation and Medication Adherence |
$ |
445,000 |
|
Jorge R. Taborga |
Executive Vice President, Engineering and Integration Management Office |
$ |
312,000 |
______________________
|
(1) |
Mr. Seidelmann joined the Company on April 2, 2018 and therefore the Committee determined not to change Mr. Seidelmann’s annualized base salary then in effect at the June 5, 2018 Committee meeting. |
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits.
OMNICELL, Inc ExhibitEX-10.1 2 exhibit101-exectuivecompen.htm EXHIBIT 10.1 Exhibit Exhibit 10.1 2018 Executive Officer Annualized Base Salaries Effective June 25,…To view the full exhibit click here
About OMNICELL,INC. (NASDAQ:OMCL)
Omnicell, Inc. (Omnicell) is a provider of automation and business information solutions designed to enable healthcare systems to streamline the medication administration process and manage medical supplies for increased operational efficiency and enhanced patient safety. The Company operates through two operating segments: Automation and Analytics, and Medication Adherence. The Automation and Analytics segment organizes the design, manufacturing, selling and servicing of medication and supply dispensing systems, pharmacy inventory management systems, and related software. The Medication Adherence segment primarily includes the manufacturing and selling of consumable medication blister cards, packaging equipment and ancillary products and services. Its product line includes OmniRx, SinglePointe, AnywhereRN, Omnicell and Pandora Data Analytics, Savvy Mobile Medication System, Central Pharmacy and Satellite Pharmacy Manager, Anesthesia Workstation and Advanced Interoperability products.
